Long-term use of PCSK9i reduces CV events, including CV death - PACE-CME

Longterm use of PCSKi reduces CV events including CV death

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

CODE-EHR, a framework for the use of EHR data in clinical research
CODE-EHR, a framework for the use of EHR data in clinical research
ESC 2022
CODE-EHR, a framework for the use of EHR data in clinical research
- Prof. Folkert Asselbergs, MD, PhD
Autoimmune diseases and risk of CVD
Autoimmune diseases and risk of CVD
ESC 2022
Autoimmune diseases and risk of CVD
- Prof. Naveed Sattar
Is class I recommendation for aspirin use in CVD prevention too strong?
Is class I recommendation for aspirin use in CVD prevention too strong?
ESC 2022
Is class I recommendation for aspirin use in CVD prevention too strong?
- Prof. John Cleland, MD
Unexpected findings when comparing DOAC with VKA in rheumatic AF
Unexpected findings when comparing DOAC with VKA in rheumatic AF
ESC 2022
Unexpected findings when comparing DOAC with VKA in rheumatic AF
- Prof. Ganesan Karthikeyan, MD